Old Web
English
Sign In
Acemap
>
authorDetail
>
Geoffrey David Peters
Geoffrey David Peters
Princess Alexandra Hospital
Pathology
Medicine
Oncology
Internal medicine
Cisplatin
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Activity and safety of third-line BRAF-targeted therapy (TT) following first-line TT and second-line immunotherapy (IT) in advanced melanoma.
2020
Journal of Clinical Oncology
Victoria Atkinson
Kathleen Batty
Georgina V. Long
Matteo S. Carlino
Geoffrey David Peters
Prachi Bhave
Maggie Moore
Wen Xu
Lauren Julia Brown
Melissa Arneil
Megan Lyle
Alexander M. Menzies
Show All
Source
Cite
Save
Citations (1)
The influence of cisplatin de-escalation on survival outcomes in oropharyngeal head and neck squamous cell carcinoma (OPC).
2017
Journal of Clinical Oncology
Geoffrey David Peters
Robin Milne
Anne Bernard
Kate Roberts
Matthew Foote
Benedict Panizza
Sandro V. Porceddu
Jermaine Coward
Show All
Source
Cite
Save
Citations (0)
1